MSL
EDIT icon

Mackay Shields LLC’s Editas Medicine EDIT Stock Holding History

Mackay Shields LLC’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30,992
Closed -$1.3M – 882
2021
Q1 		$1.3M Sell
30,992
-36,734
-54% -$2.09M 0.01% 919
2020
Q4 		$4.75M Buy
67,726
+6,000
+10% +$246K 0.03% 498
2020
Q3 		$1.73M Sell
61,726
-12,000
-16% -$391K 0.01% 850
2020
Q2 		$2.18M Buy
73,726
+8,700
+13% +$227K 0.02% 711
2020
Q1 		$1.29M Buy
65,026
+800
+1% +$20.2K 0.01% 856
2019
Q4 		$1.9M Buy
64,226
+3,300
+5% +$82.4K 0.01% 890
2019
Q3 		$1.39M Buy
60,926
+600
+1% +$14.9K 0.01% 1037
2019
Q2 		$1.49M Buy
60,326
+38,634
+178% +$922K 0.01% 1014
2019
Q1 		$531K Buy
21,692
+1,100
+5% +$24.9K ﹤0.01% 1161
2018
Q4 		$469K Sell
20,592
-1,808
-8% -$49.2K ﹤0.01% 1157
2018
Q3 		$713K Buy
22,400
+5,800
+35% +$187K 0.01% 943
2018
Q2 		$595K Buy
+16,600
New +$588K ﹤0.01% 1057

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Mackay Shields LLC's EDIT Position: Q2 2021 in Review

Mackay Shields LLC sold out of Editas Medicine (EDIT) in Q2 2021, closing a stake of 30,992 shares — an estimated $1.3M sold.

Mackay Shields LLC first reported a position in EDIT in Q2 2018 and held it in 12 quarters. The position peaked at $4.75M in Q4 2020. 313 funds tracked by Wall St. Rank hold EDIT as of Q2 2021.

  • Mackay Shields LLC reported no remaining Editas Medicine position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 30,992 Editas Medicine shares in Q2 2021, an estimated $1.3M.
  • Mackay Shields LLC first reported a position in Editas Medicine in Q2 2018 and held it in 12 quarters.
  • Mackay Shields LLC's Editas Medicine position peaked at $4.75M in Q4 2020.
  • 313 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.